Nadroparin Calcium Market

Nadroparin is an anticoagulant belonging to a class of drugs called low molecular weight heparins (LMWHs). Nadroparin is used in general and orthopedic surgery to prevent thromboembolic disorders (deep vein thrombosis and pulmonary embolism), and as treatment for deep vein thrombosis. It is also used to prevent clotting during hemodialysis, and for treatment of unstable angina and non-Q wave myocardial infarction.

Nadroparin Calcium Market contains market size and forecasts of Nadroparin Calcium in global, including the following market information:

Global Nadroparin Calcium Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Nadroparin Calcium Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Nadroparin Calcium companies in 2021 (%)

The global Nadroparin Calcium market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

3075AxaIU/0.3ml Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Nadroparin Calcium include Boehringer Ingelheim, Abbott, Bayer Healthcare AG, GlaxoSmithKline Plc, Aspen Holdings, Pfizer, Inc, Eisai Inc, Teva Pharmaceutical Industries Ltd and Mitsubishi Tanabe Pharma Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Nadroparin Calcium manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Nadroparin Calcium Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Nadroparin Calcium Market Segment Percentages, by Type, 2021 (%)

3075AxaIU/0.3ml

4100AxaIU/0.4ml

6150AxaIU/0.6ml

Global Nadroparin Calcium Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Nadroparin Calcium Market Segment Percentages, by Application, 2021 (%)

Hospitals

Clinics

Others

Global Nadroparin Calcium Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Nadroparin Calcium Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Nadroparin Calcium revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Nadroparin Calcium revenues share in global market, 2021 (%)

Key companies Nadroparin Calcium sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Nadroparin Calcium sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Boehringer Ingelheim

Abbott

Bayer Healthcare AG

GlaxoSmithKline Plc

Aspen Holdings

Pfizer, Inc

Eisai Inc

Teva Pharmaceutical Industries Ltd

Mitsubishi Tanabe Pharma Corporation

Sanofi S.A

Bristol-Myers Squibb Company

Dongcheng Biochemicals

Nanjing King-friend Biochemical Pharmaceutical

Hebei Changshan Biochemical Pharmaceutical

Tianjin Biochem Pharmaceutical

Changzhou Qianhong Bio-pharma